Solvotrin Therapeutics
Solvotrin Therapeutics is a pharmaceutical company that focuses on improving and enhancing existing medications.
Solvotrin Therapeutics has raised €6.7M across 1 funding round, most recently a round in Nov 2020. Based in Cork, Ireland; founded 2009; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€6.7M
€6,700,000
Funding rounds
1
Investors
0
distinct backers
Active since
2020-11
latest 2020-11
Funding by year
EUR raised per yearSolvotrin Therapeutics — funding by year — interactive chart.
Data table
| Solvotrin Therapeutics — funding by year | |
|---|---|
| 2020 | €6.7M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-11-03 | Other | €6.7M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Wayflyer€2.1BIreland · E-commerce
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData